Paper42621990
Immunopathogenesis of Sickle Cell Disease: Mechanisms of Immune Dysregulation and Clinical Consequences, a Narrative Review.
Egba SI and 3 others. J Blood Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Immunopathogenesis of Sickle Cell Disease: Mechanisms of Immune Dysregulation and Clinical Consequences, a Narrative Review. Papers, record 42621990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42621990
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunopathogenesis of Sickle Cell Disease: Mechanisms of Immune Dysregulation and Clinical Consequences, a Narrative Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35788790 | Sickle Cell Disease: A Review. | JAMA | 2022 | https://conductscience.org/library/papers/35788790 | PubMed |
| 2 | 29614637 | Inflammation in sickle cell disease. | Clin Hemorheol Microcirc | 2018 | https://conductscience.org/library/papers/29614637 | PubMed |
| 3 | 34073678 | Significance of Heme and Heme Degradation in the Pathogenesis of Acute Lung and Inflammatory Disorders. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34073678 | PubMed |
| 4 | 36952641 | Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease. | Blood | 2023 | https://conductscience.org/library/papers/36952641 | PubMed |
| 5 | 24589260 | Hemoglobin s polymerization and red cell membrane changes. | Hematol Oncol Clin North Am | 2014 | https://conductscience.org/library/papers/24589260 | PubMed |
| 6 | 36209107 | The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. | J Neuroinflammation | 2022 | https://conductscience.org/library/papers/36209107 | PubMed |
| 7 | 22089617 | Pathophysiological insights in sickle cell disease. | Indian J Med Res | 2011 | https://conductscience.org/library/papers/22089617 | PubMed |
| 8 | 34663697 | Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34663697 | PubMed |
| 9 | 24277079 | Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. | Blood | 2014 | https://conductscience.org/library/papers/24277079 | PubMed |
| 10 | 37817895 | Inflammasome: structure, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37817895 | PubMed |
| 11 | 40362693 | Genetic Modifiers Associated with Vaso-Occlusive Crises and Acute Pain Phenomena in Sickle Cell Disease: A Scoping Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362693 | PubMed |
| 12 | 29542687 | Sickle cell disease. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29542687 | PubMed |
| 13 | 36041706 | The NLRP3 inflammasome fires up heme-induced inflammation in hemolytic conditions. | Transl Res | 2023 | https://conductscience.org/library/papers/36041706 | PubMed |
| 14 | 33824483 | Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/33824483 | PubMed |
| 15 | 31919091 | Innate immune cells, major protagonists of sickle cell disease pathophysiology. | Haematologica | 2020 | https://conductscience.org/library/papers/31919091 | PubMed |
| 16 | 33790681 | Complement in Sickle Cell Disease: Are We Ready for Prime Time? | J Blood Med | 2021 | https://conductscience.org/library/papers/33790681 | PubMed |
| 17 | 41158674 | Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis. | Res Pract Thromb Haemost | 2025 | https://conductscience.org/library/papers/41158674 | PubMed |
| 18 | 33476407 | Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations. | Br J Haematol | 2021 | https://conductscience.org/library/papers/33476407 | PubMed |
| 19 | 40370650 | NLRP3 inflammasome: structure, mechanism, drug-induced organ toxicity, therapeutic strategies, and future perspectives. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/40370650 | PubMed |
| 20 | 39345787 | Therapeutics for sickle cell disease intravascular hemolysis. | Front Physiol | 2024 | https://conductscience.org/library/papers/39345787 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HBB | 3043 | PubTator's text mining | https://conductscience.org/library/genes/3043 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42621990
GET https://conductscience.org/api/papers/v1/42621990/references?page=2